We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESXB
2826
DELISTED
Community Bankers Trust Corporation
ESXB
| $665K | ﹤0.01% |
74,944
-6,948
| -8% | -$60.2K |
|
|
AKTS
2827
DELISTED
Akoustis Technologies Inc
AKTS
| $664K | ﹤0.01% |
83,004
+19,888
| +32% | +$155K |
|
|
ZYNE
2828
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $664K | ﹤0.01% |
109,810
-8,003
| -7% | -$54.7K |
|
2829
Infosys
INFY
$50.7B
| $663K | ﹤0.01% |
64,256
-3,647
| -5% | -$36.7K |
|
2830
Lexicon Pharmaceuticals
LXRX
$1.1B
| $658K | ﹤0.01% |
158,626
-15,081
| -9% | -$58.1K |
|
2831
MPLX
MPLX
$59.7B
| $658K | ﹤0.01% |
25,862
-62,302
| -71% | -$1.59M |
|
2832
Daily Journal
DJCO
$778M
| $655K | ﹤0.01% |
2,254
-2,076
| -48% | -$581K |
|
2833
Barnes & Noble Education
BNED
$443M
| $654K | ﹤0.01% |
1,532
-2,267
| -60% | -$932K |
|
2834
Titan International
TWI
$475M
| $654K | ﹤0.01% |
180,593
-21,957
| -11% | -$65.4K |
|
2835
South Plains Financial
SPFI
$841M
| $652K | ﹤0.01% |
31,264
+19,457
| +165% | +$353K |
|
2836
Health Catalyst
HCAT
$128M
| $651K | ﹤0.01% |
18,772
-2,373
| -11% | -$78.6K |
|
2837
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
| $649K | ﹤0.01% |
20,102
-8,440
| -30% | -$268K |
|
2838
KALA BIO
KALA
$14.5M
| $648K | ﹤0.01% |
70
+30
| +75% | +$290K |
|
|
MEN
2839
DELISTED
Blackrock Muni Enhanced Fund, Inc.
MEN
| $648K | ﹤0.01% |
58,051
| – | – |
|
2840
Replimune Group
REPL
$1.01B
| $647K | ﹤0.01% |
45,096
+15,304
| +51% | +$221K |
|
2841
Ryanair
RYAAY
$31.3B
| $644K | ﹤0.01% |
18,390
| – | – |
|
2842
Flexsteel Industries
FLXS
$311M
| $643K | ﹤0.01% |
32,296
| – | – |
|
|
ARA
2843
DELISTED
American Renal Associates Holdings, Inc
ARA
| $641K | ﹤0.01% |
61,866
-356
| -0.6% | -$3.04K |
|
|
LBC
2844
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $640K | ﹤0.01% |
55,498
+2,208
| +4% | +$25.1K |
|
2845
Target Hospitality
TH
$1.64B
| $637K | ﹤0.01% |
127,397
-165,200
| -56% | -$869K |
|
2846
AXT Inc
AXTI
$5.8B
| $632K | ﹤0.01% |
145,326
-4,871
| -3% | -$15.6K |
|
2847
Riverview Bancorp
RVSB
$108M
| $629K | ﹤0.01% |
76,564
| – | – |
|
2848
Rockwell Medical
RMTI
$28.2M
| $626K | ﹤0.01% |
2,330
+63
| +3% | +$15.8K |
|
2849
Ring Energy
REI
$339M
| $624K | ﹤0.01% |
236,421
-97,098
| -29% | -$191K |
|
2850
Unity Bancorp
UNTY
$599M
| $624K | ﹤0.01% |
27,639
| – | – |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.